Published on
A team led by professor of Epidemiology, Anne Newman, will launch a first-ever clinical trial to see if an immune regulator can reduce the deleterious aspects of aging in older but otherwise healthy adults.
A team led by professor of Epidemiology, Anne Newman, will launch a first-ever clinical trial to see if an immune regulator can reduce the deleterious aspects of aging in older but otherwise healthy adults.